Taipei, Oct. 13 (CNA) Feng Zhang (張鋒), a 2016 Tang Prize winner, explained his latest genome editing tool, called CRISPR/Cas13, in a meeting Wednesday with Tang Prize Foundation CEO Chern Jenn-chuan (陳振川) and a Nobel Prize laureate in Physiology or Medicine at the Massachusetts Institute of Technology (MIT).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan COVID-19 News Briefs: May 26
05/26/2022 09:27 PM - Society
National Police Agency establishes stalking and harassment response teams
05/26/2022 09:15 PM - Business
Taiwan unveils NT$34.56 billion COVID-19 subsidy plan
05/26/2022 07:53 PM - Politics
Taiwan upgrades website to expedite passport applications
05/26/2022 07:33 PM - Business
Taiwan, Lithuania hold high-level economic talks
05/26/2022 07:12 PM